Abstract:Neuropathic pain can result from injury to, or disease of the nervous system. It is notoriously difficult to treat. Peripheral nerve injury promotes Schwann cell activation and invasion of immunocompetent cells into the site of injury, spinal cord and higher sensory structures such as thalamus and cingulate and sensory cortices. Various cytokines, chemokines, growth factors, monoamines and neuropeptides effect two-way signalling between neurons, glia and immune cells. This promotes sustained hyperexcitability and spontaneous activity in primary afferents that is crucial for onset and persistence of pain as well as misprocessing of sensory information in the spinal cord and supraspinal structures. Much of the current understanding of pain aetiology and identification of drug targets derives from studies of the consequences of peripheral nerve injury in rodent models. Although a vast amount of information has been forthcoming, the translation of this information into the clinical arena has been minimal. Few, if any, major therapeutic approaches have appeared since the mid 1990's. This may reflect failure to recognise differences in pain processing in males vs. females, differences in cellular responses to different types of injury and differences in pain processing in humans vs. animals. Basic science and clinical approaches which seek to bridge this knowledge gap include better assessment of pain in animal models, use of pain models which better emulate human disease, and stratification of human pain phenotypes according to quantitative assessment of signs and symptoms of disease. This can lead to more personalized and effective treatments for individual patients. Significance statement: There is an urgent need to find new treatments for neuropathic pain. Although classical animal models have revealed essential features of pain aetiology such as peripheral and central sensitization and some of the molecular and cellular mechanisms involved, they do not adequately model the multiplicity of disease states or injuries that may bring forth neuropathic pain in the clinic. This review seeks to integrate information from the multiplicity of disciplines that seek to understand neuropathic pain; including immunology, cell biology, electrophysiology and biophysics, anatomy, cell biology, neurology, molecular biology, pharmacology and behavioral science. Beyond this, it underlines ongoing refinements in basic science and clinical practice that will engender improved approaches to pain management.

Strategies for measuring non-evoked pain in preclinical models of neuropathic pain: Systematic review

Non-invasive Brain Stimulation Interventions for Management of Chronic Central Neuropathic Pain: a Scoping Review Protocol

P2X3 and P2X2/3 receptors inhibition produces a consistent analgesic efficacy: A systematic review and meta-analysis of preclinical studies

In vitro models for neuropathic pain phenotypic screening in brain therapeutics

Spinal nerve ligation: An experimental model to study neuropathic pain in rats and mice

A Systematic Review and Meta-Analysis of Anxiety- and Depressive-Like Behaviors in Rodent Models of Neuropathic Pain

Neuropathic Pain After Spinal Cord Injury: Challenges and Research Perspectives

Human surrogate models of central sensitization: A critical review and practical guide

Temporal changes of spinal microglia in murine models of neuropathic pain: a scoping review

Temporal Changes of Spinal Transcriptomic Profiles in Mice With Spinal Nerve Ligation.

Neuropathic pain; what we know and what we should do about it

Transcutaneous Electrical Nerve Stimulation in Rodent Models of Neuropathic Pain: A Meta-Analysis

Innovations and advances in modelling and measuring pain in animals

Inflammatory and Neuropathic Pain Animals Exhibit Distinct Responses to Innocuous Thermal and Motoric Challenges

Pharmacological Probes to Validate Biomarkers for Analgesic Drug Development

Neuropathic pain following traumatic spinal cord injury: Models, measurement, and mechanisms

Potential Novel Therapeutic Strategies for Neuropathic Pain

Parallel Spinal Pathways for Transmitting Reflexive and Affective Dimensions of Nocifensive Behaviors Evoked by Selective Activation of the Mas-Related G Protein-Coupled Receptor D-Positive and Transient Receptor Potential Vanilloid 1-Positive Subsets of Nociceptors

Translational pain assessment: could natural animal models be the missing link?

Joint European Academy of Neurology-European Pain Federation-Neuropathic Pain Special Interest Group of the International Association for the Study of Pain guidelines on neuropathic pain assessment

Advancing Pain Understanding and Drug Discovery: Insights from Preclinical Models and Recent Research Findings